上港集團(600018.SH):董事長顧金山辭職
格隆匯7月11日丨上港集團(600018.SH)公佈,董事會於2025年7月10日收到董事長顧金山先生提交的書面辭職報告。顧金山先生因年齡原因,申請辭去公司董事長、董事職務,同時一併辭去公司董事會戰略委員會主任委員職務。辭職後顧金山先生不再擔任公司任何職務。
第三屆董事會第五十七次會議,會議經全體董事同意,審議通過了《關於推舉董事代行董事長職責的議案》。全體董事一致推舉公司董事、總裁宋曉東先生代爲履行公司董事長、董事會戰略委員會主任委員職責,代行職責的期限自本次董事會審議通過之日起至董事會選舉產生新任董事長之日止。公司將根據相關規定,按照法定程序儘快完成公司董事、董事長的選舉及董事會戰略委員會委員的補選等相關工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.